Trenbolone
A synthetic anabolic steroid with no approved human indication and extensive reports of severe adverse effects.
Medications & hormones
Research records
Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.
Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.
Trenbolone
A synthetic anabolic steroid with no approved human indication and extensive reports of severe adverse effects.
Evidence category: Preclinical. This describes the source category, not approval or certainty.
Regulatory statement in source: Not FDA-approved.
Trenbolone is a synthetic nandrolone analogue first synthesized in the 1960s for veterinary use to enhance cattle growth. A human form, Parabolan, was briefly marketed in France starting in 1980 for muscle-wasting conditions but was withdrawn in 1987 due to significant adverse effects. No approved human medical indication exists.
Benefits reported in the imported source
Risks and limits
- 90% of users report adverse effects
- Severe cardiovascular, hepatic, renal toxicity
- Psychiatric effects including aggression at higher doses
- Limited controlled human safety data
Source bottom line: No approved human medical use; only animal studies and anecdotal reports, with documented serious toxicity.
Uncertainty: Reference information only. Not medical advice.
Study protocols — reports, not instructions
No study protocol recorded in this snapshot. This does not establish that no study exists.
Community and practice descriptions
Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.
Unverified imported account — Unlocking the Power of Trenbolone Enanthate: Benefits, Risks, and Expert Tips for Bodybuilders
An imported authored paraphrase, not a quotation or a recommended protocol.
Review: unverified historical account. The imported wording is preserved for attribution; its full clinical, dosing, efficacy or consensus claims have not been independently established. Unvalidated source account; no validated human dosing population or animal-to-human equivalence is inferred.
Imported wording: An intermediate protocol shared on Swolverine describes trenbolone enanthate dosed at 300–400 mg per week for 8–10 weeks, administered twice weekly, combined with testosterone enanthate 200–300 mg/week.
Unlocking the Power of Trenbolone Enanthate: Benefits, Risks, and Expert Tips for Bodybuilders
Pharmacokinetic context
Historical half-life estimate: 72 hours. Ruiz & Strain (eds.), Lowinson and Ruiz's Substance Abuse (2011), p.358 — compiled reference, no human clinical PK trial; a veterinary/livestock compound (as Finaplix) Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.
Source references
- Adverse Effects of Trenbolone - ResearchGate (availability check 2026-10-15: source not retrieved; HTTP 403)
- Trenbolone and Psychological Distress - ScienceDirect (availability check 2026-10-15: source not retrieved; HTTP 403)
Snapshot provenance
Source ID: catalog:hormone:trenbolone. Commit: adc7684614f9439b41d91a3312b62e7982c7e20e. Review state: historical-not-reverified. Authored links are retained separately from the canonical evidence links in the public data. App templates/defaults and rejected drafts are archived, not deployed.
Related entries and components
None listed.